Images List Premium Download Classic

Infectious Disease

Infectious Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
Hycor Biomedical, Llc
July 20, 2017 - N°20170205410

A quantitative method for diagnosing an autoimmune disease or an infectious disease comprising performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, wherein the capture reagent is a biotinylated autoantigen or infectious disease antigen; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex ...
Il-33 antagonists and uses thereof
Hycor Biomedical, Llc
July 20, 2017 - N°20170204158

The present invention provides interleukin-33 (il-33) antagonists comprising one or more il-33-binding domains and one or more multimerizing domains and methods of using the same. According to certain embodiments of the invention, the il-33-binding domains can comprise an il-33-binding portion of an st2 protein and/or an extracellular portion of an il-1racp protein. The il-33 antagonists ...
Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions
United States Departmen Of Health And Human Services
July 20, 2017 - N°20170202924

Described herein are dose escalation regimens for the administration of complexes comprising interleukin-15 (“il-15”) covalently or noncovalently bound to il-15 receptor alpha (“il-15rα”) to patients in order to enhance il-15-mediated immune function. In a specific aspect, the dose escalation regimens are useful in the prevention, treatment, and/or ...
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Agents for the treatment of retroviral infectious diseases
Immunologik Gmbh
July 20, 2017 - N°20170202814

The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular hiv infections and aids, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
Cultivation method of coffee tree by red ginseng powdered extract
Immunologik Gmbh
July 20, 2017 - N°20170202235

A cultivation method of coffee tree by red ginseng powdered extract is provided, and particularly provided is a cultivation method of coffee tree through environment-friendly and rest (artificial dormant period) process using a red ginseng, and drink composition and food additive manufactured by the cultivation method of coffee tree by red ginseng, the method including: supplying red ginseng powdered extract ...
Psgl-1 modulators and uses thereof
Sanford-burnham Medical Research Institute
July 13, 2017 - N°20170198047

The present invention relates to the seminal discovery that p-selectin glycoprotein ligand-1 (psgl-1) modulates the immune system and immune responses. Specifically, the present invention provides psgl-1 agonists and antagonists which increase the survival of multifunctional t cells and viral clearance. The present invention further provides methods of treating infectious diseases, cancer and immune and inflammatory diseases and disorders using a ...
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Multispecific nkp46 binding proteins
Innate Pharma
July 13, 2017 - N°20170198038

Multispecific proteins that bind and specifically redirect nk cells to lyse a target cell of interest are provided without non-specific activation of nk cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.
Single chain antigen recognizing constructs (scarcs) stabilized by the introduction of novel disulfide bonds
Universitätsmedizin Der Johannes Gutenberg-universität Mainz
July 13, 2017 - N°20170198029

The present invention relates to a single chain antigen recognizing construct (scarc), which is composed of stabilized variable domains by the introduction of novel disulfide bonds, in order to prevent residual mis-pairing with endogenous arc chains. The invention further discloses a method for the design of a novel structurally stabilized scarc, the method being based on the visual inspection of ...
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or ...
Curevac Ag
July 13, 2017 - N°20170196967

The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a pathogenic antigen or a fragment, variant or derivative thereof, at least one histone stem-loop and a poly(a) sequence or a polyadenylation signal. Furthermore the present invention provides the use of the nucleic acid for ...
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
Immune Design Corp.
July 13, 2017 - N°20170196954

Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject a robust immune response. The methods described are therefore useful for treating and/or preventing (i. E., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of a humoral immune response and/...
Perforin 2 defense against invasive and multidrug resistant pathogens
University Of Miami
July 06, 2017 - N°20170191058

Perforin-2 (p2) is expressed by fibroblasts, microglia and macrophages and was found to be responsible for killing bacteria, for example, mycobacteria smegmatis, m. Avium, salmonellae, mrsa (drug resistant stapholococci), e. Coli. Compounds identified by screening assays are selected based on the effects of these compounds on p2. Use of these compounds in the treatment of infectious diseases, in particular, bacteria ...
New medical agents and uses thereof
Lokon Pharma Ab
July 06, 2017 - N°20170189480

The invention provides a novel compounds derived from cd154, but without the intracellular domain. Notably, the invention provides tmz-cd154 and a method to treat diseases in which the novel molecule tmz-cd154 is used. In particular, tmz-cd154 is used to modify the immune responses in patients with immune related diseases such as cancer and infectious disease. The invention also relates to ...
Composition for preventing or treating staphylococcus aureus infection
Pusan National University Industry-university Cooperation Foundation
July 06, 2017 - N°20170189473

A composition containing wall teichoic acid-attached peptidoglycan (wta-pgn) as an active ingredient, a method for preventing or treating staphylococcus aureus infectious diseases using the composition, and a method for preparing a soluble wta-pgn which can be used as an active ingredient in the composition are provided. The composition of the present invention can be effectively used for preventing or treating ...
Infectious Disease Patent Pack
Download 152+ patent application PDFs
Infectious Disease Patent Applications
Download 152+ Infectious Disease-related PDFs
For professional research & prior art discovery
inventor
  • 152+ full patent PDF documents of Infectious Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel bacteriophage and composition comprising same
Cj Cheiljedang Corporation
July 06, 2017 - N°20170189459

The present invention relates to a novel bacteriophage Φcj24 (kccm11462p) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic e. Coli of birds by using the bacteriophage Φcj24 (kccm11462p) or the composition.
Composition and method for reducing zoonotic infectious diseases
Us Biologic, Inc.
June 29, 2017 - N°20170181975

The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioacitve agent layered over a substrate and a method of reducing zoonotic infectious disease by administering ...
Self assembling nucleic acid nanostructures
Exicure, Inc.
June 22, 2017 - N°20170175121

Stable self-assembling nucleic acid nanostructures comprising: —a plurality of oligonucleotides, —a plurality of g-quadruplex forming nucleic acids linked to the plurality of oligonucleotides, and —a plurality of g-quadruplex stabilizing domains linked to the g-quadruplex forming nucleic acids. The nucleic acid nanostructures are suitable for use as agonists or antagonists of nucleic acid interacting complexes, such as toll-like ...
Icos binding proteins
Glaxosmithkline Intellectual Property Development Limited
June 22, 2017 - N°20170174767

The present invention relates to an icos binding protein or antigen binding portion thereof that is an agonist to human icos and does not induce complement, adcc, or cdc when placed in contact with a t cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said icos binding protein or antigen binding portion thereof. Further ...
Har-nds-derived stem cells, method for separating same, and use thereof
Eutilex Co., Ltd
June 22, 2017 - N°20170173077

The present invention relates to hyaluronic acid-rich node and duct system (har-nds)-derived stem cells, a method for separating the same, and a use thereof and, more specifically, to node and ductal stem cells (ndscs), which are adult stem cells having an ability to differentiate into har-nds-derived neural cells, and hematopoietic stem cells having an ability to differentiate into blood ...
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Platform Brightworks Two, Ltd.
June 22, 2017 - N°20170172971

There may be provided compositions of lipophilic pharmaceutical agents with improved solubility and stability. For example, there may be provided a non-aqueous composition that comprises a lipophilic pharmaceutical agent, and an amphiphilic polymeric solvent such as peg400 but essentially free of organic solvents and non-solubilized particles. The composition may be further diluted with a desired aqueous diluent such as an ...
Color-coded accessories indicating a medical diagnosis of a patient and enhancing patient safety
Platform Brightworks Two, Ltd.
June 22, 2017 - N°20170172236

The present invention provides color-coded accessories such as wristbands, bibs, and other patient wearables, color-coded pillows and pillow cases, and a universal chart wherein the color code is associated with a specific medical diagnosis. These accessories alert healthcare providers to the medical diagnosis of the patient and enhance patient safety by reducing medical errors during administration of treatments and medicines ...
Systems and methods for detecting infectious diseases
Theranos, Inc.
June 15, 2017 - N°20170168051

Systems, methods, and devices for detecting infections in a clinical sample are provided. Small-volume clinical samples obtained at a point-of-service (pos) location and may be tested at the pos location for multiple markers for multiple diseases, including upper and lower respiratory diseases. Samples may be tested for cytokines, or for inflammation indicators. Dilution of samples, or levels of detection, may ...
Loading